28th Jan 2021 7:00 am |
RNS |
Half Year Results 2020-21 |
22nd Jan 2021 7:00 am |
RNS |
Payment of Cash Dividend |
21st Jan 2021 9:34 am |
RNS |
Proposed acquisition of stake in Sanofi Bangladesh |
18th Jan 2021 7:00 am |
RNS |
Board Changes |
14th Jan 2021 9:00 am |
RNS |
Update on the supply of COVID-19 vaccine |
11th Jan 2021 7:00 am |
RNS |
Stock Dividend Issued |
11th Jan 2021 7:00 am |
RNS |
Confirmation of Board Changes |
21st Dec 2020 7:00 am |
RNS |
AGM Statement |
2nd Dec 2020 11:01 am |
RNS |
Board Changes |
23rd Nov 2020 7:00 am |
RNS |
Notice of AGM |
16th Nov 2020 7:00 am |
RNS |
Results for First Quarter Ended 30 September 2020 |
13th Nov 2020 7:00 am |
RNS |
Results for First Quarter Ended 30 September 2020 |
11th Nov 2020 7:00 am |
RNS |
Results for the year ended 30 June 2020 |
5th Nov 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
5th Nov 2020 4:35 pm |
RNS |
Price Monitoring Extension |
5th Nov 2020 2:40 pm |
RNS |
MOU with SII and GOB for COVID-19 vaccine |
29th Oct 2020 7:00 am |
RNS |
Notification of Preliminary Results and AGM |
21st Sep 2020 7:00 am |
RNS |
Beximco Pharma receives eighth FDA approval |
28th Aug 2020 11:06 am |
RNS |
Second Price Monitoring Extn |
28th Aug 2020 11:00 am |
RNS |
Price Monitoring Extension |
28th Aug 2020 8:31 am |
RNS |
Beximco and SII to cooperate on a COVID-19 vaccine |
30th Jul 2020 7:00 am |
RNS |
Board Change |
23rd Jun 2020 7:00 am |
RNS |
Q3 Financial Results and Business Update |
21st May 2020 7:00 am |
RNS |
World’s first generic remdesivir for COVID-19 |
4th May 2020 7:00 am |
RNS |
COVID-19 Update |
30th Mar 2020 7:00 am |
RNS |
Beximco donates PPE to healthcare professionals |
24th Feb 2020 7:00 am |
RNS |
Beximco announces Commercial Agreement with Mylan |
29th Jan 2020 7:00 am |
RNS |
Half Year Results 2019-20 |
20th Jan 2020 11:06 am |
RNS |
Payment of Cash Dividend |
23rd Dec 2019 10:46 am |
RNS |
AGM Statement |
19th Nov 2019 8:57 am |
RNS |
AGM Notification |
14th Nov 2019 7:00 am |
RNS |
Results for First Quarter Ended 30 September 2019 |
11th Nov 2019 7:00 am |
RNS |
Results for the 12 month period ended 30 June 2019 |
29th Oct 2019 7:00 am |
RNS |
Notification of Preliminary Results and AGM |
8th Aug 2019 9:18 am |
RNS |
Update on Dividend and Tax legislation changes |
30th Jul 2019 7:00 am |
RNS |
Beximco launches fifth product in the US market |
18th Jul 2019 4:01 pm |
RNS |
Dividend and Tax changes for Bangladesh companies |
29th Apr 2019 7:00 am |
RNS |
3rd Quarter Results |
24th Apr 2019 7:00 am |
RNS |
Beximco receives FDA approval for Cyproheptadine |
20th Feb 2019 7:00 am |
RNS |
Beximco Pharma to Acquire Eight ANDAs from Sandoz |